Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review

References

• Aggarwal B, Surh Y, and Shishodia S: The Molecular Targets and Therapeutic uses of Curcumin in Health and Disease. New York, NY: Springer, 2007.
   Google Scholar
• Momtazi A and Sahebkar A: Difluorinated curcumin: a promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. CPD 22, 4386–4397, 2016.
   Web of Science ®Google Scholar
• Shoba G, Joy D, Joseph T, Majeed M, Rajedendran R, et al.: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64, 353–356, 1998.
   PubMed Web of Science ®Google Scholar
• Turmeric Uses, Benefits and Dosage-Drugs.com Herbal Database. Drugs.com. 2016. Available from: https://www.drugs.com/npp/turmeric.html
   Google Scholar
• Perrone D, Ardito F, Giannatempo G, Dioguardi M, Troiano G, et al.: Biological and therapeutic activities, and anticancer properties of curcumin (Review). Expl Ther Med 10, 1615–1623, 2015.
   PubMed Web of Science ®Google Scholar
• Boominathan L: Curcumin functions as a positive regulator of miRNA processing and a negative regulator of cancer stem cell proliferation. Nat Proced 2010.
   Google Scholar
• Ruiz de Porras V, Bystrup S, Martínez-Cardús A, Pluvinet R, Sumoy L, et al.: Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway. Sci Rep 6, 24675, 2016.
   PubMed Web of Science ®Google Scholar
• Sahu B, Hazarika H, Bharadwaj R, Loying P, Baishya R, et al.: Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity. Expert Opin Drug Deliv 13, 1065–1074, 2016.
   PubMed Web of Science ®Google Scholar
• Rachakonda G, Vu T, Jin L, Samanta D, and Datta P: Role of TGF-β-induced Claudin-4 expression through c-Jun signaling in non-small cell lung cancer. Cell Signal 28, 1537–1544, 2016.
   PubMed Web of Science ®Google Scholar
• Bisht S, Schlesinger M, Rupp A, Schubert R, Nolting J, et al.: A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies. J Nanobiotechnol 14, 57, 2016.
   PubMed Web of Science ®Google Scholar
• Seo J, Kim B, Dhanasekaran D, Tsang B, and Song Y: Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells. Cancer Lett 371, 30–37, 2016.
   PubMed Web of Science ®Google Scholar
• Dricu A, Alexandru O, Georgescu A, Ene L, Purcaru S, et al.: The effect of curcumin on low-passage glioblastoma cells in vitro. J Can Res Ther 12, 1025, 2016.
   PubMed Web of Science ®Google Scholar
• Sharma V, Kumar L, Mohanty S, Maikhuri J, Rajender S, et al.: Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor-Synergistic action of quercetin and curcumin. Mol Cell Endocrinol 431, 12–23, 2016.
   PubMed Web of Science ®Google Scholar
• Lee J, Park S, Kim S, Um S, and Moon E: Curcumin hampers the antitumor effect of vinblastine via the inhibition of microtubule dynamics and mitochondrial membrane potential in HeLa cervical cancer cells. Phytomedicine 23, 705–713, 2016.
   PubMed Web of Science ®Google Scholar
• Tung C, Jian Y, Chen J, Wang T, Chen W, et al.: Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells. Naunyn-Schmiedeberg's Arch Pharmacol 389, 657–666, 2016.
   Google Scholar
• Zhou X, Wang W, Li P, Zheng Z, Tu Y, et al.: Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in inducing gastric cancer cell apoptosis both in vitro and in vivo. Oncol Res 23, 29–34, 2016.
   PubMed Web of Science ®Google Scholar
• Ooko E, Alsalim T, Saeed B, Saeed M, Kadioglu O, et al.: Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines. Toxicol Appl Pharmacol 305, 216–233, 2016.
   PubMed Web of Science ®Google Scholar
• Montgomery A, Adeyeni T, San K, Heuertz R, and Ezekiel U: Curcumin sensitizes silymarin to exert synergistic anticancer activity in colon cancer cells. J Cancer 7, 1250–1257, 2016.
   PubMed Web of Science ®Google Scholar
• Kumar D, Basu S, Parija L, Rout D, Manna S, et al.: Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells. Biomed Pharmacother 81, 31–37, 2016.
   PubMed Web of Science ®Google Scholar
• Jayakumar S, Patwardhan R, Pal D, Sharma D, and Sandur S: Dimethoxycurcumin, a metabolically stable analogue of curcumin enhances the radiosensitivity of cancer cells: possible involvement of ROS and thioredoxin reductase. Biochem Biophys Res Commun 478, 446–454, 2016.
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang J, Liu L, Yu L, Zhao N, et al.: Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction. Tumour Biol. 39, 2017.
   Google Scholar
• Zhu J, Yang X, Chen Y, Jiang Y, Wang S, et al.: Curcumin suppresses lung cancer stem cells via inhibiting Wnt/β-catenin and sonic hedgehog pathways. Phytother Res 31, 680–688, 2017.
   PubMed Web of Science ®Google Scholar
• Zhou GZ, Cao FK, Chang JM, Sun GC, and Chen XB: Mechanism of curcumin analog MHMD-induced cell death in A549 lung cancer cells. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017 [cited 17 June 2017]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=25392116.
   Google Scholar
• Xia Y, Wei X, Li W, Kanchana K, Xu C, et al.: Curcumin Analogue A501 induces G2/M arrest and apoptosis in non-small cell lung cancer cells. Asian Pac J Cancer Prev 15, 6893–6898, 2014.
   PubMedGoogle Scholar
• Zhu W, Liu S, Wu L, Xu H, Wang J, et al.: Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer. Int J Nanomedicine 12, 2621–2634, 2017.
   PubMed Web of Science ®Google Scholar
• Badrzadeh F, Akbarzadeh A, Zarghami N, Yamchi M, Zeighamian V, et al.: Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells. Asian Pac J Cancer Prev 15, 8931–8936, 2017.
   Google Scholar
• Ranjan A, Mukerjee A, Gdowski A, Helson L, Bouchard A, et al.: Curcumin-ER prolonged subcutaneous delivery for the treatment of non-small cell lung cancer. J Biomed Nanotechnol. 12, 679–688, 2016.
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu R, Xie W, Zhu M, Xie C, et al.: Curcumin reverses tobacco smoke-induced epithelial-mesenchymal transition by suppressing the MAPK pathway in the lungs of mice. Mol Med Rep 36, 190, 2017.
   Google Scholar
• Kumar U, Sharma U, and Rathi G: Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line. Tumour Biol 39, 2017.
   Google Scholar
• Jia T, Zhang L, Duan Y, Zhang M, Wang G, et al.: The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway. Cancer Cell Int 14, 126, 2014.
   PubMed Web of Science ®Google Scholar
• Gallardo M and Calaf G: Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen. Int J Oncol 48, 2534–2542, 2016.
   PubMed Web of Science ®Google Scholar
• Rao D, Liu H, Ambudkar S, and Mayer M: A combination of curcumin with either gramicidin or ouabain selectively kills cells that express the multidrug resistance-linked ABCG2 transporter. J Biol Chem 289, 31397–31410, 2014.
   PubMed Web of Science ®Google Scholar
• Guzzarlamudi S, Singh P, Pawar V, Singh Y, Sharma K, et al.: Synergistic chemotherapeutic activity of curcumin bearing methoxypolyethylene glycol-g-linoleic acid based micelles on breast cancer cells. J Nanosci Nanotechnol 16, 4180–4190, 2016.
   PubMed Web of Science ®Google Scholar
• Baek J and Cho C: A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells. Oncotarget 8, 30369–30382, 2017.
   PubMedGoogle Scholar
• Grill A, Shahani K, Koniar B, and Panyam J: Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer. Drug Deliv Trans Res 2017.
   Web of Science ®Google Scholar
• Sun Q, Zhang W, Guo Y, Li Z, Chen X, et al.: Curcumin inhibits cell growth and induces cell apoptosis through upregulation of miR-33b in gastric cancer. Tumour Biol 37, 13177–13184, 2016.
   PubMedGoogle Scholar
• Liu X, Sun K, Chen H, Song A, Zhang X, et al.: Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening. World J Surg Oncol 12, 389, 2014.
   PubMed Web of Science ®Google Scholar
• Liang T, Zhang X, Xue W, Zhao S, Zhang X, et al.: Curcumin induced human gastric cancer BGC-823 cells apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway. Int J Mol Sci 15, 15754–15765, 2014.
   PubMed Web of Science ®Google Scholar
• Tsai W, Yu K, Huang Y, and Lee C: EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles. Int J Nanomedicine 13, 903–916, 2018.
   PubMed Web of Science ®Google Scholar
• Tung L, Song S, Chan K, Choi M, Lam H, et al.: Preclinical study of novel curcumin analogue SSC-5 using orthotopic tumor xenograft model for esophageal squamous cell carcinoma. Cancer Res Treat 2018. doi:10.4143/crt.2017.353.
   Web of Science ®Google Scholar
• Ma J, Fang B, Zeng F, Pang H, Zhang J, et al.: Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells. Toxicol Lett 231, 82–91, 2014.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhu D, Chen X, Chen Q, Luo Z, et al.: Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway. Oncotarget 8, 40264–40275, 2017.
   PubMedGoogle Scholar
• Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, et al.: Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: Potential role of EMT. PLoS ONE 9, e107514, 2014.
   PubMed Web of Science ®Google Scholar
• Montazeri M, Sadeghizadeh M, Pilehvar-Soltanahmadi Y, Zarghami F, Khodi S, et al.: Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines. Int J Pharm 509, 244–254, 2016.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Xiang H, Liu JS, Li D, Fang ZY, et al.: Study on the mechanism of AMPK signaling pathway and its effect on apoptosis of human hepatocellular carcinoma SMMC-7721 cells by curcumin. [cited 2 June 2017]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=28338175.
   Google Scholar
• Zhang S, Tang D, Zang W, Yin G, Dai J, et al.: Synergistic inhibitory effect of traditional Chinese medicine astragaloside IV and curcumin on tumor growth and angiogenesis in an orthotopic nude-mouse model of human hepatocellular carcinoma. Anticancer Res 37, 465–474, 2017.
   PubMed Web of Science ®Google Scholar
• Sesarman A, Tefas L, Sylvester B, Licarete E, Rauca V, et al.: Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells. Pharmacol Rep 70, 331–339, 2017.
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu R, Xie W, Geng H, Zhao L, et al.: Curcumin Suppresses MAPK pathways to reverse tobacco smoke-induced gastric epithelial-mesenchymal transition in mice. Phytother Res 29, 1665–1671, 2015.
   PubMed Web of Science ®Google Scholar
• Zhang P, Lai ZL, Chen HF, Zhang M, Wang A, Jia T, et al.: Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice. J Exp Clin Cancer Res 36, 190–212, 2017.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ying X, Xu H, Yan H, Li X, et al.: The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals. Int J Med 12, 1369–1384, 2017.
   Google Scholar
• Sidhar H and Giri R: Induction of Bex genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells. Sci Rep 7, 41420, 2017.
   PubMed Web of Science ®Google Scholar
• Picone P, Nuzzo D, Caruana L, Messina E, Scafidi V, et al.: Curcumin induces apoptosis in human neuroblastoma cells via inhibition of AKT and Foxo3a nuclear translocation. Free Radic Res 48, 1397–1408, 2014.
   PubMed Web of Science ®Google Scholar
• Alsaab H, Alzhrani R, Kesharwani P, Sau S, Boddu S, et al.: Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma. Pharmaceutics 9, 15, 2017.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Baidoo J, Sampat S, Mancuso A, David L, et al.: Liposomal TriCurin, a synergistic combination of curcumin, epicatechin gallate and resveratrol, repolarizes tumor-associated microglia/macrophages, and eliminates glioblastoma (GBM) and GBM stem cells. Molecules 23, 201, 2018.
   PubMed Web of Science ®Google Scholar
• Maiti P, Al-Gharaibeh A, Kolli N, and Dunbar G: Solid lipid curcumin particles induce more DNA fragmentation and cell death in cultured human glioblastoma cells than does natural curcumin. Oxid Med Cell Longev 2017, 1–17, 2017.
   Web of Science ®Google Scholar
• Singh R: Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. Front Biosci 9, 235–245, 2017.
   Google Scholar
• Yang J, Wang C, Zhang Z, Chen X, Jia Y, et al.: Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway. APMIS 125, 134–140, 2017.
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu W, Li B, Zhang K, Wu Y, et al.: Curcumin promotes cell cycle arrest and inhibits survival of human renal cancer cells by negative modulation of the PI3K/AKT signaling pathway. Cell Biochem Biophys 73, 681–686, 2015.
   PubMed Web of Science ®Google Scholar
• Tian B, Zhao Y, Liang T, Ye X, Li Z, et al.: Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway. J Drug Target 25, 626–636, 2017.
   PubMed Web of Science ®Google Scholar
• Gao Y, Shi Q, Xu S, Du C, Liang L, et al.: Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder dancer cells. Int J Mol Sci 15, 15173–15187, 2014.
   PubMed Web of Science ®Google Scholar
• Moran J, Rodriguez-Velasco F, Roncero-Martin R, Vera V, and Pedrera-Zamorano J: Cytotoxic effects of curcumin in osteosarcoma cells. Int J Nanomedicine 9, 5273–5275, 2014.
   PubMed Web of Science ®Google Scholar
• Chen P, Wang H, Yang F, Chen H, He W, et al.: Curcumin promotes osteosarcoma cell death by activating miR-125a/ERRα signal pathway. J Cell Biochem 118, 74–81, 2016.
   PubMed Web of Science ®Google Scholar
• Huang L, Cai M, Xie X, Chen Y, and Luo X: Uptake enhancement of curcumin encapsulated into phosphatidylcholine-shielding micelles by cancer cells. J Biomater Sci Polym Ed 25, 1407–1424, 2014.
   PubMed Web of Science ®Google Scholar
• Hu A, Huang JJ, Jin XJ, Li JP, Tang YJ, et al.: Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017 [cited 14 June 2017]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=25628937.
   Google Scholar
• Zhen L, Fan D, Yi X, Cao X, Chen D, et al.: Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017 [cited 17 June 2017]. Available from: https://circumnavigational/pubmed/?term=25400722.
   Google Scholar
• Schwertheim S, Wein F, Lennartz K, Worm K, Schmid K, et al.: Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells. J Cancer Res Clin Oncol 143, 1143–1154, 2017.
   PubMed Web of Science ®Google Scholar
• Hosseinimehr S and Hosseini S: Radiosensitive effect of curcumin on thyroid cancer cell death induced by radioiodine-131. Interdiscip Toxicol 7, 85–88, 2014.
   PubMedGoogle Scholar
• Harati K, Behr B, Daigeler A, Hirsch T, Jacobsen F, et al.: Curcumin and viscum album extract decrease proliferation and cell viability of soft-tissue sarcoma cells: an in vitro analysis of eight cell lines using real-time monitoring and colorimetric assays. Nutr Cancer 69, 340–351, 2017.
   PubMed Web of Science ®Google Scholar
• Orr W, Denbo J, Saab K, Ng C, Wu J, et al.: Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity. PLoS ONE 8, e51309, 2013.
   PubMed Web of Science ®Google Scholar
• Iqbal B: Antiproliferative and apoptotic effect of curcumin and TRAIL (TNF related apoptosis inducing Ligand) in chronic myeloid leukaemic cells. J Clin Diagnos Res 10, XC01–XC05, 2016.
   PubMed Web of Science ®Google Scholar
• Sirohi V, Popli P, Sankhwar P, Kaushal J, Gupta K, et al.: Curcumin exhibits anti-tumor effect and attenuates cellular migration via Slit-2 mediated down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells. J Nutr Biochem 44, 60–70, 2017.
   PubMed Web of Science ®Google Scholar
• Feng W, Yang CX, Zhang L, Fang Y, and Yan M: Curcumin promotes the apoptosis of human endometrial carcinoma cells by downregulating the expression of androgen receptor through Wnt signal pathway. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017. Available from: https://circumnavigational/pubmed/?term=25556280.
   Google Scholar
• Bondì M, Emma M, Botto C, Augello G, Azzolina A, et al.: Biocompatible lipid nanoparticles as carriers to improve curcumin efficacy in ovarian cancer treatment. J Agric Food Chem 65, 1342–1352, 2017.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Hussaini R, White R, Atwi D, Fried A, et al.: TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors. Cancer Immunol Immunother 2018. doi:10.1007/s00262-018-2130-3.
   PubMed Web of Science ®Google Scholar